|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 926.60 USD | -0.05% |
|
-0.32% | -13.78% |
| 10:04pm | GLP-1 boom nudges cannabis dispensaries to rethink offerings | RE |
| 10:03pm | Eli Lilly to Strengthen Cancer Treatment Portfolio With $7 Billion Deal for Kelonia | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products | 2.83TCr | 2.85TCr | 3.41TCr | 4.5TCr | 6.52TCr | |||||
Total Assets | 4.88TCr | 4.95TCr | 6.4TCr | 7.87TCr | 11TCr | |||||
Interest Expense | -34Cr | -33Cr | -49Cr | -78Cr | - | |||||
Income Tax Expense | 57Cr | 56Cr | 131.42Cr | 209.04Cr | 509.1Cr | |||||
CAPEX | -187.32Cr | -248.4Cr | -344.76Cr | -505.78Cr | -784.1Cr | |||||
EBT | 615.55Cr | 680.64Cr | 655.46Cr | 1.27TCr | 2.57TCr | |||||
D&A | 154.76Cr | 152.25Cr | 152.73Cr | 176.66Cr | 199.7Cr | |||||
Net Income | 558.17Cr | 624.48Cr | 524.04Cr | 1.06TCr | 2.06TCr | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Veterinary Drugs | ||||||||||
Animal Health Products | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 1.68TCr | 1.82TCr | 2.18TCr | 3.04TCr | 4.35TCr | |||||
Total Assets | - | - | - | - | - | |||||
Europe | 477.68Cr | 429.92Cr | 617.47Cr | 692.07Cr | 1.16TCr | |||||
Total Assets | - | - | - | - | - | |||||
Rest of world | 270.22Cr | 285.2Cr | 294.62Cr | 427.14Cr | 605.7Cr | |||||
Total Assets | 169.1Cr | 162.59Cr | 178.42Cr | 215.89Cr | 351.6Cr | |||||
Japan | 236.7Cr | 174.73Cr | 167.26Cr | 181.49Cr | 213.2Cr | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 662Cr | 770.97Cr | 999.32Cr | 1.34TCr | 1.88TCr | |||||
Total Assets | 170.23Cr | 189.85Cr | 272.26Cr | 320.5Cr | 432.1Cr | |||||
China | 166.14Cr | 145.28Cr | 153.97Cr | 166.04Cr | 195.1Cr |
- Stock Market
- Equities
- LLY Stock
- Financials Eli Lilly and Company
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition